CAMT
Camtek Ltd.
Updated 2026-05-08
Camtek Ltd. (CAMT) Stock Price, Analysis & Forecast 2026
$197.75 ▲ 2.32%
CAMT interactive stock chart
Key statistics
0/10
4.4/10
10/10
8.9/10
7.7/10
| Market cap | $8.85B | Today’s volume | 224,901 |
| Revenue (TTM) | $496,072,000 | Avg. daily volume | N/A |
| P/E ratio | 173.97x | Today’s range | 188.935 – 201.21 |
| Debt / equity | 0.84x | 52-week range | 62.88-210.2 |
| Net margin | 10.22% | Beta | 1.625x |
| ROE | N/A% | Current ratio | 8.35x |
| Dividend & yield | $1.33 (0%) | Next earnings | 2026-05-12 |
| FCF yield | 0% | FMP rating | C+ |
| DCF fair value | $37.56 (-80.5%) | Revenue growth | 15.6% |
See also: ALGM · ARW · BMI · CRUS · ESE · All Semiconductors stocks
Is CAMT a good stock to buy in 2026?
CAMT stock exhibits a significant premium in its valuation, with a P/E ratio of 173.97x compared to the Semiconductors sector average of 60.3x. Furthermore, its discounted cash flow (DCF) fair value stands at a mere $37.56, indicating an 80.5% overvaluation against the current price. Despite these valuation concerns, 76.9% of analysts currently rate CAMT stock as a “Buy.” Not investment advice.
Significant Overvaluation
Hold Signal
2026 CAMT price scenarios
Based on analyst consensus of $165.6 from 13 analysts. Not a prediction by Alert Invest.
Key risks:
- Increased competition in advanced packaging inspection.
- Significant downturn in the broader semiconductor industry.
- Failure to innovate or adapt to new chip manufacturing technologies.
Assumes:
- Camtek Ltd. successfully meets its forward EPS estimate of $7.64.
- The company achieves its projected forward revenue of $1,076,000,000, driven by steady demand.
- Global semiconductor market experiences moderate growth without major disruptions or accelerations.
Requires:
- Exceeding forward revenue targets significantly beyond $1,076,000,000.
- Successfully launching a breakthrough product that gains substantial market share.
- Expansion into new, high-growth geographical markets or adjacent industry segments.
How does CAMT compare?
Side-by-side valuation, growth, and analyst ratings vs top Technology competitors.
About Camtek Ltd. (CAMT)
Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for the advanced interconnect packaging, memory, complementary metal oxide semiconductor image sensors, micro-electro mechanical systems, radio frequency, and other segments of the semiconductor industry. It provides inspection and metrology systems, including Eagle-i, a system that delivers 2D inspection and metrology capabilities; Eagle-AP, which addresses the advanced packaging market using software and hardware technologies that deliver superior 2D and 3D inspection and metrology capabilities on the same platform; and Golden Eagle, a panel inspection and metrology system to support fanout wafer level packaging applications. The company sells its products in the Asia Pacific, the United States, and Europe.
Under the leadership of CEO Rafi Amit, Camtek Ltd. operates with a dedicated team of approximately 656 employees, specializing in inspection and metrology equipment for the semiconductor industry. The company’s distinctive strength lies in its highly specialized technology, particularly its Eagle-i and Eagle-AP systems, which offer advanced 2D and 3D inspection capabilities crucial for complex semiconductor manufacturing. This focus on high-precision solutions in advanced interconnect packaging and memory segments provides CAMT stock with a competitive edge in a demanding market.
CAMT competitive moat and business analysis
Camtek Ltd. maintains a net profit margin of 10.22%, indicating efficient operations within the competitive semiconductor equipment sector. While specific Return on Equity (ROE) and Return on Invested Capital (ROIC) figures are not available (N/A), the company’s strong gross margin of 50.46% suggests a robust ability to control direct costs and potentially derive value from its proprietary technology. This margin strength underscores a strong competitive advantage in producing specialized inspection and metrology solutions that are critical for semiconductor manufacturing.
Camtek’s revenue streams primarily derive from the sale of its advanced inspection and metrology equipment globally. While detailed segment and geographical breakdowns for fiscal year 2025 are not explicitly provided by the data, the company’s business description indicates a focus on various semiconductor segments including advanced interconnect packaging and memory. Geographically, Camtek sells its products in the Asia Pacific, the United States, and Europe, reflecting a diversified customer base across key semiconductor manufacturing regions.
The company has demonstrated solid growth, with revenue increasing by 15.6% year-over-year to $496,072,000. This growth trajectory suggests that Camtek is effectively capitalizing on the ongoing demand for advanced semiconductor inspection solutions. Given the absence of specific transcript quotes, this consistent revenue expansion points to a strengthening market position and successful product adoption, reinforcing its economic moat in a sector constantly driven by technological advancements.
When evaluating CAMT stock against its peers in the Technology sector, particularly within the Semiconductors industry, its specialized focus on inspection equipment stands out. Investors might consider comparing Camtek’s operational efficiency and market penetration to companies like Allegro MicroSystems (ALGM), Arrow Electronics (ARW), and Biomérieux (BMI) to understand relative strengths and weaknesses. A deeper dive into these comparisons, such as CAMT vs ALGM, CAMT vs ARW, and CAMT vs BMI, would offer insights into market share, innovation, and long-term potential within the semiconductor supply chain.
Camtek Ltd. analyst rating
Based on 13 analysts. 76.9% rate CAMT Buy or Strong Buy.
Buy76.9%
Hold23.1%
Sell0.0%
A 76.9% “Buy” rating from analysts is generally considered a strong endorsement, particularly within the Technology sector where innovation and market dynamics can lead to diverse opinions. This high percentage suggests significant confidence in the future performance of CAMT stock among the analyst community, despite current valuation challenges.
CAMT financial scorecard
Comprehensive ranking of CAMT across four financial dimensions.
4.0/10
| Metric | Value | Signal & strength |
|---|---|---|
| Debt / equity | 0.84x | Moderate |
| Current ratio | 8.35x | Healthy |
| FCF yield | 0% | Weak |
| DCF vs price | -80.5% | Overvalued |
| FMP debt score | 1/5 | Below avg |
6/10
| Metric | Value | Signal & strength |
|---|---|---|
| Gross margin | 50.46% | Excellent |
| Net margin | 10.22% | Good |
| EBITDA margin | 25.84% | Good |
| ROE | N/A | Low |
| ROA | N/A | Low |
| FMP ROE score | 3/5 | Average |
10/10
| Metric | Value | Signal & strength |
|---|---|---|
| Revenue growth YoY | +15.6% | Accelerating |
| Revenue (TTM) | $496,072,000 | Large scale |
| Forward EPS est. | $7.64 | Analyst consensus |
| Forward revenue | $1.1B | Analyst consensus |
| FMP DCF score | 3/5 | Average |
2.0/10
| Metric | Value | Signal & strength |
|---|---|---|
| P/E ratio | 173.97x | Expensive |
| P/B ratio | 14.3x | Expensive |
| P/S ratio | 17.84x | Expensive |
| DCF fair value | $37.56 | Overvalued |
| FMP P/E score | 1/5 | Below avg |
| FMP overall | 2/5 | Weak |
Is CAMT undervalued or overvalued?
vs 60.3x sector
Expensive
Expensive
-80.5%
Negative
-14.2% downside
Assessing CAMT valuation reveals a substantial premium compared to its industry peers. With a trailing P/E ratio of 173.97x, Camtek Ltd. trades at significantly higher multiples than the Semiconductors sector average of 60.3x. This premium suggests that investors are pricing in considerable future growth expectations for CAMT stock, or that the stock may be overvalued relative to its current earnings power.
Further analysis using a Discounted Cash Flow (DCF) model points to a fair value of $37.56, indicating an 80.5% disparity from its current trading price. This DCF valuation suggests that, from a fundamental perspective, CAMT stock might be significantly overvalued. While growth prospects can justify some premium, such a large divergence between market price and intrinsic value warrants careful consideration for investors looking at CAMT valuation.
CAMT financial health & key metrics
| Metric | CAMT | Sector avg | Signal |
|---|---|---|---|
| P/E ratio | 173.97x | 60.3x | Expensive |
| Net margin | 10.22% | — | Good |
| ROE / ROIC | N/A | — | N/A |
| Debt / equity | 0.84x | — | Moderate |
| FCF yield | 0% | — | Weak |
| Revenue growth | 15.6% | — | Strong |
| DCF fair value | $37.56 | — | Overvalued |
For value investors, the current financial health of CAMT stock presents a mixed picture. While the company boasts a healthy net margin of 10.22% and robust revenue growth of 15.6%, its valuation metrics are a significant red flag. The P/E ratio of 173.97x, vastly exceeding the sector average, alongside a DCF fair value of $37.56 that suggests an 80.5% overvaluation, indicates that CAMT stock is trading at a premium not supported by its current fundamentals. Its moderate debt-to-equity of 0.84x and weak FCF yield of 0% further complicate its appeal for those prioritizing intrinsic value and strong free cash flow generation.
Camtek Ltd. earnings history & next report
Camtek Ltd. reported EPS of $0.81, missing estimates by 2.41%. Next earnings: 2026-05-12 with EPS estimate of $0.69.
As Camtek Ltd. approaches its next earnings report on 2026-05-12, investors will be closely watching for several key indicators, especially following the recent EPS miss. The estimated EPS for the upcoming report is $0.69, and exceeding this figure will be crucial for investor sentiment. Beyond the headline numbers, attention should be paid to management’s commentary on demand trends in the semiconductor industry, particularly within advanced packaging and memory segments. Any updates on new product adoption, manufacturing efficiencies, or geographical expansion will provide insights into the company’s ability to sustain its revenue growth and address its high CAMT stock valuation.
CAMT daily short volume
Short volume data from FINRA CNMS Consolidated — shares sold short in the most recent US trading session. A high short ratio can signal bearish conviction or a potential short squeeze. Updated every trading day.
| Metric | Value | Context |
|---|---|---|
| Short volume ratio | 67.9% | >60% = dominant short pressure |
| Shares sold short | 73.5K | FINRA-reported for 2026-05-07 |
| Total reported volume | 108.3K | All FINRA ATS + OTC volume |
| Exempt short volume | 3 | Market-maker / arbitrage exempt trades |
| Signal | High bearish pressure | FINRA CNMS Consolidated |
CAMT insider trading activity
Corporate insiders must report trades to the SEC within two business days.
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-13 | Amit Rafi | Officer: Chief Executive Officer | Sale | 0 | N/A | $0 | SEC |
| 2026-04-13 | Amit Rafi | Officer: Chief Executive Officer | Sale | 0 | N/A | $0 | SEC |
| 2026-04-13 | Amit Rafi | Officer: Chief Executive Officer | Sale | 0 | N/A | $0 | SEC |
| 2026-04-13 | Amit Rafi | Officer: Chief Executive Officer | Sale | 0 | N/A | $0 | SEC |
| 2026-04-13 | Amit Rafi | Officer: Chief Executive Officer | Sale | 0 | N/A | $0 | SEC |
| 2026-04-13 | Amit Rafi | Officer: Chief Executive Officer | Sale | 0 | N/A | $0 | SEC |
Source: SEC Form 4 via EDGAR · Data: Financial Modeling Prep · Not investment advice
Recent CAMT analyst rating changes
| Firm | Previous | New rating | Date | Action | |
|---|---|---|---|---|---|
| Stifel | Buy | → | Hold | 2026-04-17 | Reiterated |
| Morgan Stanley | Equal Weight | → | Equal Weight | 2026-03-24 | Reiterated |
| Stifel | Buy | → | Buy | 2026-02-19 | Reiterated |
| Barclays | Overweight | → | Overweight | 2026-02-19 | Reiterated |
| Needham | Buy | → | Buy | 2026-02-19 | Reiterated |
Camtek Ltd. stock news today
There has been no major news or press releases for Camtek Ltd. (CAMT) reported this week. Investors should monitor financial news outlets for any breaking developments concerning CAMT stock.
How does CAMT compare to its peers?
When considering an investment in CAMT stock, it’s beneficial to analyze its performance and position relative to key competitors in the broader Technology and Semiconductors industry. Understanding how Camtek Ltd. stacks up against companies like Allegro MicroSystems (ALGM), Arrow Electronics (ARW), and Biomérieux (BMI) can provide valuable context regarding market share, innovation, and long-term growth prospects. These peer comparisons help investors gauge whether CAMT is a good stock relative to alternative opportunities.
Allegro MicroSystems is a global leader in designing, developing, manufacturing, and marketing high-performance semiconductors. It primarily serves the automotive and industrial markets with sensor ICs and power ICs.
Arrow Electronics is a global provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. They act as a supply channel partner for electronic component manufacturers and computer products manufacturers.
Biomérieux is a French biotechnology company that provides diagnostic solutions. While not directly in semiconductors, it operates in the broader technology and healthcare sector, often considered a peer for diversified technology portfolios.
Alert Invest · Free Newsletter
Get alerts when top investors buy a stock!
Track when institutional investors, insiders, and analysts change their positions. Alert Invest sends you a data-driven brief the moment it happens — free, every week.
- Institutional & insider moves
- Analyst upgrades & downgrades
- 100% free — unsubscribe anytime
FAQ — Camtek Ltd. (CAMT) stock
For informational purposes only. Not investment advice. Data: Financial Modeling Prep & SEC EDGAR. Always do your own research.
